Malaysia medical devices and diagnostics market valued at USD 2.5 billion, driven by aging population, rising healthcare expenditure, and tech advancements.

Malaysia Medical or Healthcare Market size was valued at USD 27.87 Billion in 2024 and is projected to reach USD 84.11 Billion by 2032 growing at a CAGR of 14.8% during the forecast period 2026-2032.Malaysia Medical or Healthcare Market DriversThe market drivers for the Malaysia medical or healthcare market can be influenced by various factors. These may include:Aging Population Demographics: A demographic shift toward an aging population is being experienced by Malaysia. Healthcare demand is being driven by the increasing need for chronic disease management and age-related medical services across the country.Government Healthcare Investment: Significant budget allocations for healthcare infrastructure are being made by the Malaysian government. Health facilities are being expanded and new clinics are being built to increase capacity and reduce overcrowding.

Malaysia Cardiovascular Devices Market was valued at USD 4.14 billion in 2024 and is expected to reach USD 5.84 billion by 2030 with a CAGR of 5.90%.

The Malaysia Medical Tourism market is projected to be valued at 2.5 billion USD in 2024, driven by factors such as increasing consumer awareness and the rising prevalence of industry-specific trends. The market is expected to grow at a CAGR of 10%, reaching approximately 6.5 billion USD by 2034.

The size of the Southeast Asia Diabetes Devices Market market was valued at USD 2.09 billion in 2024 and is projected to reach USD 3.91 billion by 2033, with an expected CAGR of 9.36 % during the forecast period. Recent developments include: In February 2024, Duopharma Biotech Berhad partnered with Owen Mumford Sdn Bhd, a UK-based medical device manufacturer Owen Mumford subsidiary, to distribute a range of diabetes care products in Brunei, Malaysia, and Singapore. The partnership aims to provide better access to medical devices for needy patients, particularly those with diabetes , In April 2022, Gan & Lee Pharmaceuticals, a leading pharmaceutical company, announced the approval of its insulin pen in Thailand. This approval marks a significant milestone for the company as it expands its presence in the Southeast Asian market. The insulin pen is a crucial medical device for individuals with diabetes, allowing for convenient and accurate insulin delivery , In April 2021, Dexcom, a prominent U.S.-based diabetes care technology provider, planned to establish a significant manufacturing presence in Malaysia. The company intends to construct a sprawling 1.8 million square feet manufacturing facility in the country, marking its first foray into establishing a production site in Asia. Dexcom’s decision to expand its operations into Malaysia underscores its strategic vision to enhance its global footprint and cater to the growing demand for innovative diabetes management solutions in the region .

GlobalData, the industry analysis specialist, has released its latest report, “CountryFocus: Healthcare, Regulatory and Reimbursement Landscape – Malaysia”. The report is an essential source of information and analysis on the healthcare, regulatory and reimbursement landscape in Malaysia. It identifies the key trends in the healthcare market and provides insights into the demographic, regulatory, reimbursement landscape and healthcare infrastructure of Malaysia. Most importantly, the report provides valuable insights into the trends and segmentation of the pharmaceutical and medical device markets. It is built using data and information sourced from proprietary databases, secondary research, and in-house analysis by GlobalData’s team of industry experts.
The Malaysian pharmaceutical market is one of the major markets in the South East Asian region. It was valued at $1.55B in 2010, which increased to $3.46 in 2013. However, since 2015 it decreased to reach an estimated $1.94B in 2018. The decline was due to the launch of several generic drugs in the market along with the depreciation of the Malaysian Ringgit against the US Dollar. However, rising income, demographic changes and high incidence of non-communicable diseases (NCDs) are expected to drive the market in the future. The Malaysian medical device market was worth $1.28B in 2015, which increased to $1.55B in 2018. It is expected to grow at a CAGR of 9.5% from $1.74B in 2019 to $2.28B in 2022 Read More

According to Cognitive Market Research, the global Used and Refurbished Medical Imaging Equipments market size will be USD XX million in 2025. It will expand at a compound annual growth rate (CAGR) of XX% from 2025 to 2033.

North America held the major market share for more than XX% of the global revenue with a market size of USD XX million in 2025 and will grow at a CAGR of XX% from 2025 to 2033.
Europe accounted for a market share of over XX% of the global revenue with a market size of USD XX million in 2025 and will grow at a CAGR of XX% from 2025 to 2033.
Asia Pacific held a market share of around XX% of the global revenue with a market size of USD XX million in 2025 and will grow at a CAGR of XX% from 2025 to 2033.
Latin America had a market share of more than XX% of the global revenue with a market size of USD XX million in 2025 and will grow at a CAGR of XX% from 2025 to 2033.
Middle East and Africa had a market share of around XX% of the global revenue and was estimated at a market size of USD XX million in 2025 and will grow at a CAGR of XX% from 2025 to 2033.

Market Drivers

Rising Demand for Affordable Diagnostics Drives Market Growth

One of the primary drivers of the used and refurbished imaging equipment market is the growing need for affordable diagnostic solutions in low- and middle-income countries. As the global burden of non-communicable diseases (NCDs) such as cancer, cardiovascular disease, and neurological disorders continues to rise, access to imaging becomes essential for timely detection and intervention. However, the high cost of new MRI or CT systems often acts as a barrier, especially for small clinics and private hospitals in emerging regions. (Source: Availability of essential diagnostics in ten low-income and middle-income countries: results from national health facility surveys - The Lancet Global Health) Refurbished systems offer a viable alternative, enabling healthcare providers to access modern imaging technologies without compromising on quality. Certified vendors often provide comprehensive overhauls, warranty coverage, and installation support, making these systems operationally reliable. For example, organizations such as WHO and UNICEF have endorsed refurbished equipment procurement in resource-limited settings as part of broader efforts to expand diagnostic capacity in Africa and South Asia. (Source: Methods for medical device and equipment procurement and prioritization within low- and middle-income countries: findings of a systematic literature review - PMC)

Sustainability and Circular Economy Trends Support Market Expansion

The shift toward environmental sustainability in the healthcare sector is further accelerating the demand for refurbished medical imaging equipment. Hospitals and health systems are increasingly adopting circular economy models, which prioritize equipment reuse, refurbishment, and lifecycle extension to reduce environmental impact. This approach aligns with broader ESG (Environmental, Social, and Governance) goals adopted by healthcare institutions worldwide. Manufacturers and third-party vendors have responded by creating dedicated refurbishment programs with ISO 13485 certification and FDA/CE compliance. These programs ensure that equipment undergoes rigorous quality control, software upgrades, and performance validation. As environmental regulations become stricter and public procurement policies evolve, refurbished medical devices are gaining wider acceptance in both public and private healthcare systems.

Restraint

Regulatory Complexity and Stigma around Used Equipment Limit Market Growth

Despite growing acceptance, the used and refurbished imaging equipment market faces challenges related to regulatory inconsistency and lingering perceptions about quality. Regulatory frameworks governing the sale of refurbished medical equipment vary significantly across regions. While the EU and U.S. have well-established pathways for certified refurbishment, several countries in Latin America, Africa, and Southeast Asia lack standardized protocols, leading to market fragmentation and import restrictions. (Source: Full article: Regulatory landscape, risks, and solutions for refurbished medical devices: a comparative analysis in the US, EU, Malaysia, and Ghana) In addition, there remains a psychological barrier among some healthcare providers who view used equipment as inferior or less reliable. This stigma ...

Malaysia 3D Metrology System Market size was valued at USD 180 Million in 2024 and is projected to reach USD 310 Million by 2032, growing at a CAGR of 7.8% from 2026 to 2032.Malaysia 3D Metrology System Market DriversThe market drivers for the Malaysia 3D metrology system market can be influenced by various factors. These may include:• Adoption of Precision Manufacturing Standards: The adoption of precision manufacturing standards is expected to drive reliance on 3D metrology systems for dimensional accuracy across automotive and electronics supply chains, with the Malaysian Investment Development Authority (MIDA) reporting that over 40% of new manufacturing projects are aligned with Industry 4.0 compliance.

The Malaysia Diabetes Care Devices market, valued at $321.71 million in 2025, is projected to experience robust growth, driven by rising diabetes prevalence, increasing awareness of advanced diabetes management, and government initiatives promoting better healthcare access. The market's Compound Annual Growth Rate (CAGR) of 4.70% from 2019 to 2024 suggests a continued upward trajectory through 2033. Key segments include monitoring devices (self-monitoring blood glucose devices like glucometers, test strips, and lancets, as well as continuous glucose monitoring systems), and management devices (insulin pumps, syringes, cartridges, and disposable pens). The increasing adoption of continuous glucose monitoring (CGM) systems, offering real-time glucose data, is a significant growth driver, along with the rising preference for convenient insulin delivery systems like insulin pumps. However, high device costs and limited healthcare insurance coverage in certain segments of the population could pose challenges. Furthermore, the market's growth is also influenced by factors such as technological advancements leading to more accurate and user-friendly devices, increased investment in diabetes research and development, and growing public-private partnerships aimed at improving diabetes care infrastructure in Malaysia. Major players like Becton Dickinson, Medtronic, Insulet, Tandem, Ypsomed, Novo Nordisk, Sanofi, Eli Lilly, Abbott, Roche, and Lifescan (Johnson & Johnson) are competing intensely to capture market share, focusing on product innovation and strategic partnerships to expand their reach. The market's segmentation provides opportunities for specialized players to target specific needs within the diabetes care spectrum. Further expansion is expected through improvements in affordability, accessibility, and targeted educational campaigns to raise awareness about diabetes management and the benefits of using these devices. The forecast period (2025-2033) presents a promising outlook for investors and stakeholders in the Malaysian diabetes care devices market, fueled by continued advancements in technology and growing patient needs. Recent developments include: June 2023: Dexcom, a San Diego-based company specializing in continuous glucose monitors, has announced its intention to release a new wearable device in 2024. This device is specifically designed for individuals with Type 2 diabetes who do not require insulin, and is expected to contribute to the growing popularity of wearable health monitors., May 2023: Medtronic plc has recently disclosed its plans to acquire EOFlow Co. Ltd., a renowned manufacturer of the EOPatch device. This innovative insulin delivery device is tubeless, wearable, and fully disposable. By incorporating EOFlow into its portfolio, Medtronic aims to enhance its capacity to cater to a larger population of individuals with diabetes. This strategic move, coupled with Medtronic's advanced Meal Detection Technology algorithm and next-generation continuous glucose monitor (CGM), is anticipated to significantly broaden the company's capabilities in meeting the diverse requirements of people living with diabetes.. Notable trends are: Management Devices Hold Highest Market Share in Malaysia Diabetes Care Devices Market.

Malaysia Laser Marking Machine Market size was valued at USD 1.3 Billion in 2024 and is projected to reach USD 2.4 Billion by 2032, growing at a CAGR of 8% during the forecast period. i.e., 2026-2032.Malaysia Laser Marking Machine Market DriversThe market drivers for the Malaysia laser marking machine market can be influenced by various factors. These may include:Electronics Manufacturing Hub: Malaysia serves as a major production center for semiconductors, consumer electronics, and automotive components requiring precise product identification. Global electronics companies operating in the country need laser marking machines for serial numbers, barcodes, and traceability codes on circuit boards and electronic devices.Automotive Industry Expansion: Malaysia's growing automotive sector, including Proton and Perodua manufacturing, drives demand for laser marking on engine parts, chassis components, and safety-critical items. Vehicle manufacturers require permanent marking solutions for part identification, quality control, and regulatory compliance throughout the production process.Medical Device Manufacturing: The country's expanding medical device production industry requires laser marking for surgical instruments, implants, and diagnostic equipment. Regulatory standards mandate permanent, biocompatible marking on medical products, creating steady demand for specialized laser systems that meet healthcare industry requirements.Government Industry 4.0 Initiative: Malaysia's national digitalization program encourages manufacturers to adopt smart manufacturing technologies including automated marking systems. Government incentives and funding support help companies invest in laser marking equipment as part of broader factory automation and digital transformation efforts.